WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective treatment
WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer.
FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, that blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases. It’s an approach that previously eluded drugmakers for decades.
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly…
U.S. health officials have approved a groundbreaking pancreatic cancer drug that offers a new approach to treating the deadly…
Pancreatic cancer is among the deadliest forms, largely because detection is difficult before malignancy spreads to other organs
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for…
FDA officials gave expedited approval to daraxonrasib, which blocks a mutated protein that fuels tumor growth
First-of-its-kind pill targets a mutation that fuels more than 90% of pancreatic cancers.
FDA approves landmark pancreatic cancer drug that's shown to improve survival
FDA Approves Landmark Pancreatic Cancer Drug That's Shown To Improve Survival
New hope for pancreatic cancer patients after FDA approves drug to improve survival
FDA approves new pancreatic cancer drug that could extend patients' lives
Pancreatic cancer drug Daraxonrasib gets approval from FDA: All you need to know
FDA approves groundbreaking pancreatic cancer drug
FDA approves breakthrough drug to treat advanced pancreatic cancer
Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN
FDA Approves New Pancreatic Cancer Drug After Stunning Trial Results
U.S. approves breakthrough pancreatic cancer drug, heralding a new era for an intractable disease
